Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per shar
-
Shares outstanding
-
22,457,615
-
Total 13F shares
-
588,048
-
Share change
-
+107,575
-
Total reported value
-
$202,288
-
Price per share
-
$0.34
-
Number of holders
-
10
-
Value change
-
+$35,854
-
Number of buys
-
8
-
Number of sells
-
2
Institutional Holders of Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) as of Q1 2025
As of 31 Mar 2025,
Catheter Precision, Inc. - Common Stock, par value $0.0001 per shar (VTAK) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
588,048 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Warberg Asset Management LLC, GEODE CAPITAL MANAGEMENT, LLC, XTX Topco Ltd, CITADEL ADVISORS LLC, TWO SIGMA SECURITIES, LLC, Tower Research Capital LLC (TRC), UBS Group AG, HARBOUR INVESTMENTS, INC., and BANK OF AMERICA CORP /DE/.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.